Triple-negative breast cancer (TNBC), the most aggressive subtype of breast cancer, refers to a broad category of breast cancer that tests negative for estrogen receptors (ER), progesterone receptors (PRs), and human epidermal growth factor receptor 2 (HER2). Here, ESR1 is linked to triple-negative breast carcinoma.